Literature DB >> 18647985

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics.

Diane V Havlir1, Haileyesus Getahun, Ian Sanne, Paul Nunn.   

Abstract

Tuberculosis (TB) and the emerging multidrug-resistant TB epidemic represent major challenges to human immunodeficiency virus (HIV) care and treatment programs in resource-limited settings. Tuberculosis is a major cause of mortality among patients with HIV and poses a risk throughout the course of HIV disease, even after successful initiation of antiretroviral therapy (ART). Progress in the implementation of activities directed at reducing TB burden in the HIV population lags far behind global targets. HIV programs designed for longitudinal care are ideally suited to implement TB control measures and have no option but to address TB vigorously to save patient lives, to safeguard the massive investment in HIV treatment, and to curb the global TB burden. We propose a framework of strategic actions for HIV care programs to optimally integrate TB into their services. The core activities of this framework include intensified TB case finding, treatment of TB, isoniazid preventive treatment, infection control, administration of ART, TB recording and reporting, and joint efforts of HIV and TB programs at the national and local levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647985     DOI: 10.1001/jama.300.4.423

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  54 in total

1.  Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis.

Authors:  Maunank Shah; Neil A Martinson; Richard E Chaisson; Desmond J Martin; Ebrahim Variava; Susan E Dorman
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

2.  Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Authors:  Diane V Havlir; Michelle A Kendall; Prudence Ive; Johnstone Kumwenda; Susan Swindells; Sarojini S Qasba; Anne F Luetkemeyer; Evelyn Hogg; James F Rooney; Xingye Wu; Mina C Hosseinipour; Umesh Lalloo; Valdilea G Veloso; Fatuma F Some; N Kumarasamy; Nesri Padayatchi; Breno R Santos; Stewart Reid; James Hakim; Lerato Mohapi; Peter Mugyenyi; Jorge Sanchez; Javier R Lama; Jean W Pape; Alejandro Sanchez; Aida Asmelash; Evans Moko; Fred Sawe; Janet Andersen; Ian Sanne
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

Review 3.  Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Authors:  Maunank Shah; Colleen Hanrahan; Zhuo Yu Wang; Nandini Dendukuri; Stephen D Lawn; Claudia M Denkinger; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2016-05-10

4.  Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis.

Authors:  Alice A Zwerling; Maitreyi Sahu; Lucky G Ngwira; McEwen Khundi; Tina Harawa; Elizabeth L Corbett; Richard E Chaisson; David W Dowdy
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

5.  Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa.

Authors:  Adrienne E Shapiro; Ebrahim Variava; Modiehi H Rakgokong; Neshen Moodley; Binnu Luke; Saeed Salimi; Richard E Chaisson; Jonathan E Golub; Neil A Martinson
Journal:  Am J Respir Crit Care Med       Date:  2012-03-15       Impact factor: 21.405

6.  Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study.

Authors:  Anya Sarang; Tim Rhodes; Nicolas Sheon
Journal:  Health Policy Plan       Date:  2012-11-28       Impact factor: 3.344

7.  Control of Mycobacterium tuberculosis growth by activated natural killer cells.

Authors:  C Guerra; K Johal; D Morris; S Moreno; O Alvarado; D Gray; M Tanzil; D Pearce; V Venketaraman
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

8.  Characteristics of Poor Tuberculosis Treatment Outcomes among Patients with Pulmonary Tuberculosis in Community Hospitals of Thailand.

Authors:  Sakarn Charoensakulchai; Manasak Limsakul; Inkharat Saengungsumalee; Sirawich Usawachoke; Aticha Udomdech; Anintita Pongsaboripat; Wisit Kaewput; Boonsub Sakboonyarat; Ram Rangsin; Picha Suwannahitatorn; Mathirut Mungthin; Phunlerd Piyaraj
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

9.  A trend analysis and sub-regional distribution in number of people living with HIV and dying with TB in Africa, 1991 to 2006.

Authors:  Olalekan A Uthman; Ismail Yahaya; Khalid Ashfaq; Mubashir B Uthman
Journal:  Int J Health Geogr       Date:  2009-11-24       Impact factor: 3.918

10.  Feasibility of provider-initiated HIV testing and counselling of tuberculosis patients under the TB control programme in two districts of South India.

Authors:  Sophia Vijay; Soumya Swaminathan; Preetish Vaidyanathan; Aleyamma Thomas; L S Chauhan; Prahlad Kumar; Sonali Chiddarwar; Beena Thomas; Puneet K Dewan
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.